Evaluation of Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Patients With/Without Substitution Therapy in Austria.

Trial Profile

Evaluation of Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Patients With/Without Substitution Therapy in Austria.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Nov 2013

At a glance

  • Drugs Buprenorphine; Methadone; Morphine; Peginterferon alfa-2b; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Apr 2012 Actual patient number changed from 333 to 353 as reported by ClinicalTrials.gov.
    • 15 Apr 2011 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.
    • 28 Jan 2011 Planned end date changed from Nov 2010 to Mar 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top